CWHM-12

CAS No. 1564286-55-0

CWHM-12 ( CWHM12; CWHM 12; CWHM-12. )

Catalog No. M12231 CAS No. 1564286-55-0

A novel active RGD peptidomimetic inhibitor of αv integrin with IC50s of 1.8/0.8/61/1.5/0.2 nM for αvβ1/αvβ3/αvβ5/αvβ6/αvβ8; no inhibition on αIIbβ3, α2β1 and α10β1 (>50 uM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 43 Get Quote
5MG 72 Get Quote
10MG 115 Get Quote
25MG 210 Get Quote
50MG 350 Get Quote
100MG 521 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    CWHM-12
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel active RGD peptidomimetic inhibitor of αv integrin with IC50s of 1.8/0.8/61/1.5/0.2 nM for αvβ1/αvβ3/αvβ5/αvβ6/αvβ8; no inhibition on αIIbβ3, α2β1 and α10β1 (>50 uM).
  • Description
    A novel active RGD peptidomimetic inhibitor of αv integrin with IC50s of 1.8/0.8/61/1.5/0.2 nM for αvβ1/αvβ3/αvβ5/αvβ6/αvβ8; no inhibition on αIIbβ3, α2β1 and α10β1 (>50 uM); significantly inhibits progression of pulmonary fibrosis in mice model.Cystic Fibrosis Preclinical
  • Synonyms
    CWHM12; CWHM 12; CWHM-12.
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Integrin
  • Recptor
    Integrin
  • Research Area
    Other Indications
  • Indication
    Fibrosis

Chemical Information

  • CAS Number
    1564286-55-0
  • Formula Weight
    590.47
  • Molecular Formula
    C26H32BrN5O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10.5 mg/mL
  • SMILES
    OC1=CC(C(NCC(N[C@@H](CC(O)=O)C2=CC(Br)=CC(C(C)(C)C)=C2)=O)=O)=CC(NC3=NCC(O)CN3)=C1
  • Chemical Name
    β-Alanine, N-[3-hydroxy-5-[(1,4,5,6-tetrahydro-5-hydroxy-2-pyrimidinyl)amino]benzoyl]glycyl-3-[3-bromo-5-(1,1-dimethylethyl)phenyl]-, (3S)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Henderson NC, et al. Nat Med. 2013 Dec;19(12):1617-24.
2. Ulmasov B, et al. Cell Mol Gastroenterol Hepatol. 2016 Mar 16;2(4):499-518.
molnova catalog
related products
  • OSU-T315

    A novel potent, orally active ILK (integrin-linked kinase) inhibitor with IC50 of 0.6 uM.

  • Arg-Gly-Asp TFA

    RGD Trifluoroacetate is a tripeptide that effectively triggers cell adhesion addresses certain cell lines and elicits specific cell responses; binds to?integrins.

  • Vedolizumab

    Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.